To mark World AIDS Day, the Ministry of Solidarity and Health and Santé publique France are launching a prevention campaign aimed at promoting HIV testing services. The goal is to raise awareness of the various testing methods available and their advantages. Each year in France, approximately 6,000 people discover they are HIV-positive, more than a quarter of whom are at an advanced stage of infection. Furthermore, an estimated 25,000 people are unaware of their HIV status: approximately 40% are men who have sex with men (MSM), 40% are heterosexual migrants, mainly from sub-Saharan Africa, and 20% are heterosexuals born in France. These individuals therefore do not receive effective treatment and may unwittingly transmit the virus to others. Identifying undiagnosed individuals and reducing the time between infection and diagnosis are major public health objectives.In 2016, according to data from Santé publique France, the number of new HIV diagnoses is estimated at approximately 6,000, 27% of which were made at an advanced stage of infection. The overall number of new diagnoses decreased by 5% compared to 2013 but remains stable among MSM (2,600 in 2016¹). MSM and heterosexuals born abroad (three-quarters of whom were born in a sub-Saharan African country) remain the two most affected groups, accounting for 44% and 39% of diagnoses in 2016, respectively. Heterosexuals born in France and people who inject drugs account for 15% and 1%, respectively. The latest data published in a special issue of the Weekly Epidemiological Bulletin confirm that, to help reduce the number of infected but undiagnosed individuals, existing screening measures are complementary. Thus, in 2016: The number of serological tests performed by clinical laboratories increased by 3% between 2014 and 2016. The proportion of confirmed positive serological tests was 2 per 1,000. Rapid diagnostic tests (RDTs) accounted for a smaller number of tests, but the positivity rate was higher (8.7 per 1,000).Data from mandatory HIV reporting show that co-infections with sexually transmitted infections (STIs) are common at the time of HIV diagnosis or within the 12 months preceding that diagnosis. They underscore the importance of combining HIV screening with screening for other STIs. In the context of diversified prevention, it is particularly important to repeat STI testing to treat patients and their partners. In recent years, testing options have expanded. There are now four ways to get tested for HIV and/or STIs: On December 1, the Ministry of Solidarity and Health and Santé publique France are launching a prevention campaign featuring four visuals highlighting the benefits of each testing method, with the tagline "HIV testing methods adapt to your life." The goal is to break down psychological barriers—such as the stress of waiting for results or the fear of being stigmatized—and practical barriers—such as the difficulty of finding time or securing an appointment. The campaign is aimed at everyone, including populations most at risk for HIV (men who have sex with men and migrants from sub-Saharan Africa). It takes the following forms: The campaign visuals are also available as postcards for healthcare professionals wishing to inform their patients. The entire campaign directs people to their primary care physician and the Sida-Info-Service website for more information.